India, Oct. 23 -- Fischer Medical Ventures Ltd. (FMVL) announced that its portfolio company, Nanomedic Technologies Ltd., has achieved key global milestones, including registration of its flagship wound-care product SpinCare® with the UK's National Health Service (NHS), progress toward entry into the Indian market, and preparations for a US FDA submission.
UK Breakthrough: NHS Approval and Hospital Collaboration
Nanomedic has successfully registered SpinCare® with the NHS, marking a major regulatory achievement that enables access to one of the world's most influential healthcare systems. The company has also begun collaborating with one of London's largest hospitals to strengthen its presence in the UK. With this approval, SpinCa...